查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
细胞化验分析市场：按产品、技术、应用、最终用户、地区划分 - 到 2029 年的预测
市场调查报告书
商品编码
1556882

细胞化验分析市场：按产品、技术、应用、最终用户、地区划分 - 到 2029 年的预测

Cell Based Assays Market by Offering (Reagents, Assays Kits, Cell Lines, Microplates, Probes, Labels, Instruments & Software), Technology (Flowcytometry, HTS), Application (Drug Discovery (Toxicity, Pharmacokinetics), Research) - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 454 Pages | 订单完成后即时交付

价格

细胞化验分析市场规模预计将从 2024 年的 173 亿美元增加到 2029 年的 243 亿美元，2024-2029 年预测期间复合年增长率为 7.1%。

该市场的成长是由于对药物发现的需求不断增加以及药物发现中细胞化验分析的需求不断增加。製药和生物技术行业不断增加的研发投资正在推动细胞化验分析市场的成长。此外，癌症发生率的增加推动了对先进治疗方法的需求，从而促进了细胞化验分析市场的成长。此外，细胞化验分析在慢性疾病和个人化医疗中的广泛应用预计将在未来几年推动市场成长。

调查范围
调查年份 2022-2029
基准年 2023年
预测期 2024-2029
考虑单位 金额（美元） 数量（1,000 单位）
按细分市场 按产品、按技术、按应用、按最终用户、按地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东/非洲

根据应用，细胞化验分析市场分为药物发现、基础研究、基因研究等。药物发现部分进一步分为毒性测试、药物动力学测试和动态测试。 2023年，按应用划分，药物发现领域在全球细胞化验分析市场中占据最大份额。癌症发生率的增加推动了对先进药物的需求，从而推动了细胞化验分析市场的成长。此外，不断增加的研发投资、新药的推出以及为製药和生物技术公司提供药物发现服务的受託研究机构数量的增加预计也将成为推动 Masu细胞化验分析市场成长的动力。

依技术划分，细胞化验分析市场分为流式细胞技术、高通量筛检、无标定检测和其他技术。到2023年，按技术划分，流式细胞技术领域将占据全球细胞化验分析市场的主要份额。流式细胞技术细分的增长主要是由于流式细胞技术广泛用于细胞化验分析以执行多种测量。此外，细胞分析和细胞表征先进技术的日益采用预计将促进细胞化验分析市场的细分市场成长。

该报告探讨了全球细胞化验分析市场，包括按产品、技术、应用、最终用户、地区和参与市场的公司概况分類的趋势。

目录

第一章 简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 介绍
  • 市场动态
  • 技术分析
  • 供应链分析
  • 价值链分析
  • 价格分析
  • 生态系分析
  • 影响客户业务的趋势/干扰
  • 专利分析
  • 2024-2025年重大会议和活动
  • 监管状况
  • 波特五力分析
  • 主要相关人员和采购标准
  • 投资金筹措场景
  • 贸易分析
  • 人工智慧/生成人工智慧对细胞化验分析市场的影响

第六章细胞化验分析市场（按产品）

  • 介绍
  • 消耗品
  • 装置
  • 服务
  • 软体

第七章细胞化验分析市场（按技术）

  • 介绍
  • 流式细胞技术
  • 高通量筛检
  • 无标定检测
  • 其他的

第八章细胞化验分析市场（按应用）

  • 介绍
  • 药物发现
  • 基础调查
  • 遗传学研究
  • 其他的

第九章细胞化验分析市场（按最终用户）

  • 介绍
  • 製药和生物技术公司
  • CRO
  • 学术研究所

第 10 章细胞化验分析市场（按地区）

  • 介绍
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第十一章竞争格局

  • 概述
  • 主要参与企业的策略/秘密
  • 收益分析
  • 市场占有率分析
  • 企业评估矩阵：主要参与企业，2023
  • 企业评估矩阵：Start-Ups/小型企业，2023 年
  • 评价及财务指标
  • 品牌/产品比较
  • 竞争场景

第十二章 公司简介

  • 介绍
  • 主要参与企业
    • DANAHER CORPORATION
    • THERMO FISHER SCIENTIFIC INC.
    • MERCK KGAA
    • BD
    • AGILENT TECHNOLOGIES, INC.
    • LONZA
    • EUROFINS SCIENTIFIC
    • CHARLES RIVER LABORATORIES
    • BIO-RAD LABORATORIES, INC.
    • REVVITY
    • SARTORIUS AG
    • CORNING INCORPORATED
    • PROMEGA CORPORATION
    • CELL SIGNALING TECHNOLOGY, INC.
    • ENZO BIOCHEM INC.
    • CARNA BIOSCIENCES, INC.
    • INTERTEK GROUP PLC
    • BICO
  • 其他公司
    • CELL BIOLABS, INC.
    • REACTION BIOLOGY
    • AAT BIOQUEST, INC.
    • PESTKA BIOMEDICAL LABORATORIES, INC.
    • NEUROMICS
    • BPS BIOSCIENCE, INC.
    • BELLBROOK LABS
    • PROFACGEN
    • BMG LABTECH
    • HANUGEN THERAPEUTICS
    • ALTOGEN LABS
    • BIOAGILYTIX

第13章讨论指南

Product Code: BT 2486

The cell-based assays market is projected to reach USD 24.3 billion by 2029 from an estimated USD 17.3 billion in 2024, at a CAGR of 7.1% during the forecast period from 2024 to 2029. The growth of this market can be attributed to the increasing need of drug discovery and growing demand for cell-based assays in drug discovery. The rising R&D investments by pharmaceutical & biotechnology industries is propelling the growth of cell-based assays market. Also, growing incidences of cancer is promoting the need of advanced therapies resulting to boost the growth of cell-based assays market. Moreover, growing applications of cell-based assays in chronic diseases and personalized medicine is expected to propel the market growth in coming years.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD) Volume (Thousand Units)
SegmentsBy Offering, Technology, Application, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

"The drug discovery segment accounted for the largest share of by application segment in 2023."

Based on application, cell-based assays market is segmented into drug discovery, basic research, genetic studies, and other applications. Drug discovery segment is further categories into toxicity studies, pharmacokinetic studies, and pharmacodynamic studies. In 2023, the drug discovery segment accounted for the largest share of the global cell-based assays market by application. Increasing prevalence of cancer is driving the need of advanced thearpies resulting to promote segment's growth in the cell-based assays market. Additionally, increasing R&D investments, the introduction of new drugs, and the growing number of contract research organizations providing drug discovery services to pharmaceutical and biotechnology companies are also expected to drive to promote the segment's growth in cell-based assays market.

"The flow cytometry segment accounted for the major share by technology segment in 2023."

Based on technology, cell-based assays market is segmented into flow cytometry, high throughput screening, label free detection, and other technologies. In 2023, the flow cytometry segment accounted for the major share of the global cell-based assays market by technology. The growth of the flow cytometry segment is primarily attributed to the wide usage of flow cytometry for cell-based assays to perform multiple measurements. Additionally, growing adoption of advanced technologies for cell analysis and cell characterization is anticipated to boost the segment growth in cell-based assays market.

"The US has continued to dominate the cell-based assays market in 2023."

Based on the region, the cell-based assays market is segmented into six major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, US dominated the cell-based assays market in North America. The US is the world's largest biopharmaceutical market and a leader in biopharmaceutical research/investments. The US also has a strong healthcare infrastructure, which drives research and development in the life sciences sector. Additionally, the significant presence of many biopharmaceutical companies and growing research activities in the biotechnology industry are propelling market growth in the US. Moreover, growing focus on development of advanced cell-based therapies due to growing incidences of cancer is also driving the growth of the cell-based assays market.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 60% and Demand Side 40%
  • By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
  • By Region: North America - 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

  • BD (US)
  • Thermo Fisher Scientific Inc. (US)
  • Danaher Corporation (US)
  • Merck KGaA (Germany)
  • Agilent Technologies, Inc. (US)
  • Lonza (Switzerland)
  • Charles River Laboratories (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Revvity (US)
  • Sartorius AG (Germany)
  • Corning Incorporated (US)
  • Promega Corporation (US)
  • Cell Signaling Technology, Inc. (US)
  • Eurofins Scientific (Luxembourg)
  • Enzo Biochem, Inc. (US)
  • Carna Biosciences, Inc. (Japan)
  • Intertek Group plc (UK)
  • BICO (Sweden)
  • Cell Biolabs, Inc. (US)
  • Reaction Biology (US)
  • AAT Bioquest, Inc. (US)
  • Pestka Biomedical Laboratories, Inc. (US)
  • Neuromics (US)
  • BPS Bioscience, Inc. (US)
  • BellBrook Labs (US)
  • Profacgen (US)
  • BMG LABTECH (Germany)
  • Hanugen Theraputics (India)
  • Altogen Labs (US)
  • BioAgilytix (US)

Research Coverage:

This research report categorizes the cell-based assays market by offering (consumables (reagents, assay kits (reporter gene assays, cell growth assays, second messenger assays, cell death assays, and other assay kits), microplates, cell line (immortalized cell lines, primary cell lines, and stem cell lines), probes & labels, and other consumables), instruments, software, and services, technology (flow cytometry, high throughput screening, label-free detection, and other technologies), application (drug discovery (toxicology, pharmacodynamics, and pharmacokinetics), basic research, genetic studies, and other applications), end user (pharmaceutical & biopharmaceutical companies, contract research organizations (CROs), and academic & research institutes), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the cell-based assays market. A thorough analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. Also, it includes new product launches, collaborations and acquisitions, and recent developments associated with the cell-based assays market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall cell-based assays market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (rising demand for drug discovery & development and increasing preference for cell-based assays in drug discovery, surge in cases of cancer, and increasing R&D investments and fundings for cell-based research), restraints (high cost of instruments and restrictions imposed by product end-user licenses for reagents), opportunities (growing applications of cell-based assays in chronic diseases and personalized medicine), and Challenges (complexities in assay designs) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on newly launched products of the cell-based assays market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell-based assays market
  • Competitive Assessment: BD (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Lonza (Switzerland), Charles River Laboratories (US), Bio-Rad Laboratories, Inc. (US), Revvity (US), Sartorius AG (Germany), Corning Incorporated (US), Promega Corporation (US), Cell Signaling Technology, Inc. (US), Eurofins Scientific (Luxembourg), Enzo Biochem, Inc. (US), Carna Biosciences, Inc. (Japan), Intertek Group plc (UK), BICO (Sweden), Cell Biolabs, Inc. (US), Reaction Biology (US), AAT Bioquest, Inc. (US), Pestka Biomedical Laboratories, Inc. (US) , Neuromics (US), BPS Bioscience, Inc. (US), BellBrook Labs (US), Profacgen (US), BMG LABTECH (Germany), Hanugen Theraputics (India), Altogen Labs (US), and BioAgilytix (US), among others in the market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
    • 2.2.3 TOP-DOWN APPROACH
  • 2.3 MARKET GROWTH RATE PROJECTIONS
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 CELL-BASED ASSAYS MARKET OVERVIEW
  • 4.2 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER AND COUNTRY (2023)
  • 4.3 CELL-BASED ASSAYS MARKET, BY OFFERING, 2023
  • 4.4 CELL-BASED ASSAYS MARKET, BY END USER, 2023
  • 4.5 CELL-BASED ASSAYS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing demand for drug discovery & development and increasing preference for cell-based assays in drug discovery
      • 5.2.1.2 Government support and funding for cell-based research
      • 5.2.1.3 Growing efforts to curtail animal-based studies
      • 5.2.1.4 Rising prevalence of cancer
      • 5.2.1.5 Alliances to accelerate innovations in drug discovery
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of instruments and restrictions imposed by product end-user licenses for reagents
      • 5.2.2.2 Lack of standardization of protocols used in cell-based assays
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing applications of cell-based assays in chronic diseases and personalized medicine
      • 5.2.3.2 Growth opportunities in emerging economies
      • 5.2.3.3 Rising adoption of AI in drug discovery and cell analysis
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Complexities in assay designs
      • 5.2.4.2 Shortage of skilled professionals
  • 5.3 TECHNOLOGY ANALYSIS
    • 5.3.1 KEY TECHNOLOGIES
      • 5.3.1.1 Flow Cytometry
      • 5.3.1.2 High-throughput screening
      • 5.3.1.3 High-content screening
      • 5.3.1.4 Label-free detection
    • 5.3.2 COMPLEMENTARY TECHNOLOGIES
      • 5.3.2.1 Artificial intelligence and machine learning
    • 5.3.3 ADJACENT TECHNOLOGIES
      • 5.3.3.1 Nanotechnology
  • 5.4 SUPPLY CHAIN ANALYSIS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 PRICING ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • 5.7.1 RAW MATERIAL VENDORS
    • 5.7.2 PRODUCT/SERVICE VENDORS
    • 5.7.3 END USERS
    • 5.7.4 REGULATORY BODIES
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.9 PATENT ANALYSIS
    • 5.9.1 PATENT METHODOLOGY
    • 5.9.2 PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
    • 5.9.3 INNOVATION & PATENT APPLICATIONS
    • 5.9.4 TOP APPLICANTS
  • 5.10 KEY CONFERENCES & EVENTS, 2024-2025
  • 5.11 REGULATORY LANDSCAPE
    • 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.11.2 REGULATORY SCENARIO
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • 5.12.1 THREAT OF NEW ENTRANTS
    • 5.12.2 THREAT OF SUBSTITUTES
    • 5.12.3 BARGAINING POWER OF SUPPLIERS
    • 5.12.4 BARGAINING POWER OF BUYERS
    • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.13.2 BUYING CRITERIA
  • 5.14 INVESTMENT & FUNDING SCENARIO
  • 5.15 TRADE ANALYSIS
  • 5.16 IMPACT OF AI/GENERATIVE AI ON CELL-BASED ASSAYS MARKET

6 CELL-BASED ASSAYS MARKET, BY OFFERING

  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    • 6.2.1 REAGENTS
      • 6.2.1.1 High demand for reagents in research applications to propel market growth
    • 6.2.2 ASSAY KITS
      • 6.2.2.1 Reporter gene assays
        • 6.2.2.1.1 Versatility of reporter gene assays and widespread applications to fuel growth
      • 6.2.2.2 Cell growth assays
        • 6.2.2.2.1 Rising use of cell viability and cell proliferation assays for assessing cell growth to boost market
      • 6.2.2.3 Second messenger assays
        • 6.2.2.3.1 Adoption of secondary messenger assays for cell signaling studies to fuel growth
      • 6.2.2.4 Cell death assays
        • 6.2.2.4.1 Importance of cell death quantification in drug development to favor growth
      • 6.2.2.5 Other assay kits
    • 6.2.3 MICROPLATES
      • 6.2.3.1 Demand for microplates in assay development to drive market
    • 6.2.4 CELL LINES
      • 6.2.4.1 Immortalized cell lines
        • 6.2.4.1.1 Wide use of immortalized cell lines to boost market
      • 6.2.4.2 Primary cell lines
        • 6.2.4.2.1 Advantages in drug development, preclinical research, and other applications to propel market
      • 6.2.4.3 Stem cell lines
        • 6.2.4.3.1 Rising use in tissue and disease models to fuel adoption
    • 6.2.5 PROBES & LABELS
      • 6.2.5.1 Growing need for effective cell labeling to boost demand
    • 6.2.6 OTHER CONSUMABLES
  • 6.3 INSTRUMENTS
    • 6.3.1 AUTOMATION IN INSTRUMENTS TO DRIVE SEGMENTAL GROWTH
  • 6.4 SERVICES
    • 6.4.1 GROWING NUMBER OF CROS PROVIDING DRUG DISCOVERY AND SCREENING SERVICES TO ACCELERATE GROWTH
  • 6.5 SOFTWARE
    • 6.5.1 INCREASING ADOPTION OF SOFTWARE FOR EFFICIENT DATA ANALYSIS TO DRIVE GROWTH

7 CELL-BASED ASSAYS MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
  • 7.2 FLOW CYTOMETRY
    • 7.2.1 WIDE USAGE OF FLOW CYTOMETRY IN CELL-BASED ASSAYS TO DRIVE MARKET
  • 7.3 HIGH-THROUGHPUT SCREENING
    • 7.3.1 INCREASING INVESTMENTS AND FUNDING FOR LIFE SCIENCE RESEARCH TO SUPPORT MARKET GROWTH
  • 7.4 LABEL-FREE DETECTION
    • 7.4.1 GROWING ADOPTION OF ADVANCED TECHNOLOGIES TO DRIVE DEMAND
  • 7.5 OTHER TECHNOLOGIES

8 CELL-BASED ASSAYS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 DRUG DISCOVERY
    • 8.2.1 TOXICITY STUDIES
      • 8.2.1.1 Increasing demand for cell-based assays in toxicity testing to fuel growth
    • 8.2.2 PHARMACOKINETIC STUDIES
      • 8.2.2.1 Growing focus on ADME studies in pharmacokinetics to propel demand for cell-based assays
    • 8.2.3 PHARMACODYNAMIC STUDIES
      • 8.2.3.1 Advantages of cell-based assays in pharmacodynamics to propel growth
  • 8.3 BASIC RESEARCH
    • 8.3.1 INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES
  • 8.4 GENETIC STUDIES
    • 8.4.1 INCREASING FUNDING FOR GENETIC RESEARCH TO DRIVE MARKET
  • 8.5 OTHER APPLICATIONS

9 CELL-BASED ASSAYS MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO HOLD LARGEST SHARE OF END-USER MARKET
  • 9.3 CONTRACT RESEARCH ORGANIZATIONS
    • 9.3.1 GROWING PREFERENCE FOR OUTSOURCING TO DRIVE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH
  • 9.4 ACADEMIC & RESEARCH INSTITUTES
    • 9.4.1 RISING FOCUS ON DEVELOPING ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE MARKET

10 CELL-BASED ASSAYS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
    • 10.2.2 US
      • 10.2.2.1 US to dominate North American cell-based assays market during forecast period
    • 10.2.3 CANADA
      • 10.2.3.1 Increasing funding and investments to drive market in Canada
  • 10.3 EUROPE
    • 10.3.1 EUROPE: MACROECONOMIC OUTLOOK
    • 10.3.2 GERMANY
      • 10.3.2.1 Germany to dominate cell-based assays market in Europe
    • 10.3.3 UK
      • 10.3.3.1 Growing cancer research funding to increase demand for cell-based assays
    • 10.3.4 FRANCE
      • 10.3.4.1 Growing biotechnology sector to drive market
    • 10.3.5 ITALY
      • 10.3.5.1 Growing pharmaceutical industry in Italy to boost market
    • 10.3.6 SPAIN
      • 10.3.6.1 Rising research activity and increasing number of biotech companies to favor market growth
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
    • 10.4.2 CHINA
      • 10.4.2.1 Increasing R&D expenditure to favor market growth
    • 10.4.3 JAPAN
      • 10.4.3.1 Government initiatives for drug innovation to support market growth
    • 10.4.4 INDIA
      • 10.4.4.1 Increasing investments in R&D and funding for life science research to propel market
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Booming life science sector to propel market
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Increasing strategic alliances to support market growth
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
    • 10.5.2 BRAZIL
      • 10.5.2.1 Brazil to hold largest share of Latin American market
    • 10.5.3 MEXICO
      • 10.5.3.1 Government support for biopharmaceutical production to support market growth
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST
    • 10.6.1 MIDDLE EAST: MACROECONOMIC OUTLOOK
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Saudi Arabia
        • 10.6.2.1.1 Increasing R&D investments to drive market
      • 10.6.2.2 UAE
        • 10.6.2.2.1 Investments and support for biopharma sector to offer growth opportunities
      • 10.6.2.3 Rest of GCC Countries
    • 10.6.3 REST OF MIDDLE EAST
  • 10.7 AFRICA
    • 10.7.1 RISING NEED FOR EFFECTIVE DIAGNOSTICS TO SUPPORT MARKET GROWTH
    • 10.7.2 AFRICA: MACROECONOMIC OUTLOOK

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN CELL-BASED ASSAYS MARKET
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Offering footprint
      • 11.5.5.3 Technology footprint
      • 11.5.5.4 Application Footprint
      • 11.5.5.5 Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 VALUATION AND FINANCIAL METRICS
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
    • 11.9.2 DEALS
    • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYERS
    • 12.2.1 DANAHER CORPORATION
      • 12.2.1.1 Business overview
      • 12.2.1.2 Products/Services offered
      • 12.2.1.3 Recent developments
        • 12.2.1.3.1 Deals
        • 12.2.1.3.2 Expansions
      • 12.2.1.4 MnM view
        • 12.2.1.4.1 Key strengths
        • 12.2.1.4.2 Strategic choices
        • 12.2.1.4.3 Weaknesses & competitive threats
    • 12.2.2 THERMO FISHER SCIENTIFIC INC.
      • 12.2.2.1 Business overview
      • 12.2.2.2 Products/Services offered
      • 12.2.2.3 Recent developments
        • 12.2.2.3.1 Deals
        • 12.2.2.3.2 Expansions
      • 12.2.2.4 MnM view
        • 12.2.2.4.1 Key strengths
        • 12.2.2.4.2 Strategic choices
        • 12.2.2.4.3 Weaknesses and competitive threats
    • 12.2.3 MERCK KGAA
      • 12.2.3.1 Business overview
      • 12.2.3.2 Products/Services offered
      • 12.2.3.3 Recent developments
        • 12.2.3.3.1 Deals
        • 12.2.3.3.2 Expansions
      • 12.2.3.4 MnM view
        • 12.2.3.4.1 Key strengths
        • 12.2.3.4.2 Strategic choices
        • 12.2.3.4.3 Weaknesses and competitive threats
    • 12.2.4 BD
      • 12.2.4.1 Business overview
      • 12.2.4.2 Products/Services offered
      • 12.2.4.3 Recent developments
        • 12.2.4.3.1 Product launches
        • 12.2.4.3.2 Deals
      • 12.2.4.4 MnM view
        • 12.2.4.4.1 Key strengths
        • 12.2.4.4.2 Strategic choices
        • 12.2.4.4.3 Weaknesses and competitive threats
    • 12.2.5 AGILENT TECHNOLOGIES, INC.
      • 12.2.5.1 Business overview
      • 12.2.5.2 Products/Services offered
      • 12.2.5.3 Recent developments
        • 12.2.5.3.1 Product launches
      • 12.2.5.4 MnM view
        • 12.2.5.4.1 Key strengths
        • 12.2.5.4.2 Strategic choices
        • 12.2.5.4.3 Weaknesses & competitive threats
    • 12.2.6 LONZA
      • 12.2.6.1 Business overview
      • 12.2.6.2 Products/Services offered
      • 12.2.6.3 Recent developments
        • 12.2.6.3.1 Deals
        • 12.2.6.3.2 Expansions
    • 12.2.7 EUROFINS SCIENTIFIC
      • 12.2.7.1 Business overview
      • 12.2.7.2 Products/Services offered
      • 12.2.7.3 Recent developments
        • 12.2.7.3.1 Deals
    • 12.2.8 CHARLES RIVER LABORATORIES
      • 12.2.8.1 Business overview
      • 12.2.8.2 Products/services offered
      • 12.2.8.3 Recent developments
        • 12.2.8.3.1 Service launches
        • 12.2.8.3.2 Deals
    • 12.2.9 BIO-RAD LABORATORIES, INC.
      • 12.2.9.1 Business overview
      • 12.2.9.2 Products/Services offered
    • 12.2.10 REVVITY
      • 12.2.10.1 Business overview
      • 12.2.10.2 Products/Services offered
      • 12.2.10.3 Recent developments
        • 12.2.10.3.1 Product launches
    • 12.2.11 SARTORIUS AG
      • 12.2.11.1 Business overview
      • 12.2.11.2 Products/Services offered
      • 12.2.11.3 Recent developments
        • 12.2.11.3.1 Expansions
    • 12.2.12 CORNING INCORPORATED
      • 12.2.12.1 Business overview
      • 12.2.12.2 Products/Services offered
    • 12.2.13 PROMEGA CORPORATION
      • 12.2.13.1 Business overview
      • 12.2.13.2 Products/Services offered
    • 12.2.14 CELL SIGNALING TECHNOLOGY, INC.
      • 12.2.14.1 Business overview
      • 12.2.14.2 Products/Services offered
    • 12.2.15 ENZO BIOCHEM INC.
      • 12.2.15.1 Business overview
      • 12.2.15.2 Products/Services offered
      • 12.2.15.3 Recent developments
        • 12.2.15.3.1 Expansions
    • 12.2.16 CARNA BIOSCIENCES, INC.
      • 12.2.16.1 Business overview
      • 12.2.16.2 Products/Services offered
    • 12.2.17 INTERTEK GROUP PLC
      • 12.2.17.1 Business overview
      • 12.2.17.2 Products/services offered
    • 12.2.18 BICO
      • 12.2.18.1 Business overview
      • 12.2.18.2 Products/Services offered
  • 12.3 OTHER PLAYERS
    • 12.3.1 CELL BIOLABS, INC.
    • 12.3.2 REACTION BIOLOGY
    • 12.3.3 AAT BIOQUEST, INC.
    • 12.3.4 PESTKA BIOMEDICAL LABORATORIES, INC.
    • 12.3.5 NEUROMICS
    • 12.3.6 BPS BIOSCIENCE, INC.
    • 12.3.7 BELLBROOK LABS
    • 12.3.8 PROFACGEN
    • 12.3.9 BMG LABTECH
    • 12.3.10 HANUGEN THERAPEUTICS
    • 12.3.11 ALTOGEN LABS
    • 12.3.12 BIOAGILYTIX

13 DISCUSSION GUIDE

  • 13.1 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.2 CUSTOMIZATION OPTIONS
  • 13.3 RELATED REPORTS
  • 13.4 AUTHOR DETAILS

List of Tables

  • TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 2 CELL-BASED ASSAYS MARKET: IMPACT ANALYSIS
  • TABLE 3 ESTIMATED EXPENDITURE BY US NIH FOR STEM CELL RESEARCH, 2019-2025
  • TABLE 4 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2022 VS. 2035
  • TABLE 5 CELL-BASED ASSAYS MARKET: KEY DEVELOPMENTS REPORTED, BY PLAYER
  • TABLE 6 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2021-2023
  • TABLE 7 AVERAGE SELLING PRICE FOR CELL-BASED ASSAYS, BY REGION, 2023
  • TABLE 8 CELL-BASED ASSAYS MARKET: ROLE OF RAW MATERIAL VENDORS
  • TABLE 9 CELL-BASED ASSAYS MARKET: ROLE OF PRODUCT/SERVICE VENDORS
  • TABLE 10 CELL-BASED ASSAYS MARKET: ROLE OF END USERS
  • TABLE 11 CELL-BASED ASSAYS MARKET: ROLE OF REGULATORY BODIES
  • TABLE 12 PATENTS FILED, 2014-2024
  • TABLE 13 TOP 20 PATENT OWNERS IN CELL-BASED ASSAYS MARKET, 2014-2024
  • TABLE 14 INDICATIVE LIST OF PATENTS IN CELL-BASED ASSAYS MARKET
  • TABLE 15 CELL-BASED ASSAYS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS
  • TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 CELL-BASED ASSAYS MARKET: REGULATORY GUIDELINES
  • TABLE 21 CELL-BASED ASSAYS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 22 BUYING CRITERIA FOR CELL-BASED ASSAY PRODUCTS, BY END USER
  • TABLE 23 IMPORT VALUE FOR HS CODE 9027 (TOP 20 COUNTRIES), 2019-2023 (USD THOUSAND)
  • TABLE 24 EXPORT VALUE FOR HS CODE 9027 (TOP 20 COUNTRIES), 2019-2023 (USD THOUSAND)
  • TABLE 25 IMPORT VOLUME FOR HS CODE 9027 (TOP 20 COUNTRIES), 2019-2023 (TONS)
  • TABLE 26 EXPORT VOLUME FOR HS CODE 9027 (TOP 20 COUNTRIES), 2019-2023 (TONS)
  • TABLE 27 CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 28 CONSUMABLES OFFERED, BY KEY COMPANY
  • TABLE 29 CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 30 CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 31 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 MIDDLE EAST: CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 36 GCC COUNTRIES: CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 37 REAGENTS OFFERED, BY KEY COMPANY
  • TABLE 38 REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 39 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 40 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 43 MIDDLE EAST: REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 44 GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 ASSAY KITS OFFERED, BY KEY COMPANY
  • TABLE 46 ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 47 ASSAY KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 48 NORTH AMERICA: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 49 EUROPE: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 50 ASIA PACIFIC: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 51 LATIN AMERICA: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 52 MIDDLE EAST: ASSAY KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 53 GCC COUNTRIES: ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 54 REPORTER GENE ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 55 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 56 EUROPE: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 57 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 58 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 59 MIDDLE EAST: REPORTER GENE ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 60 GCC COUNTRIES: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 61 CELL GROWTH ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 62 NORTH AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 63 EUROPE: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 65 LATIN AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 66 MIDDLE EAST: CELL GROWTH ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 67 GCC COUNTRIES: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 68 SECONDARY MESSENGER ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 69 NORTH AMERICA: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 70 EUROPE: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 72 LATIN AMERICA: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 73 MIDDLE EAST: SECONDARY MESSENGER ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 74 GCC COUNTRIES: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 75 CELL DEATH ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 77 EUROPE: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 79 LATIN AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 80 MIDDLE EAST: CELL DEATH ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 81 GCC COUNTRIES: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 82 OTHER ASSAY KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 83 NORTH AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 84 EUROPE: OTHER ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: OTHER ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 86 LATIN AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 87 MIDDLE EAST: OTHER ASSAY KITS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 88 GCC COUNTRIES: OTHER ASSAY KITS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 89 MICROPLATES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: MICROPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 91 EUROPE: MICROPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: MICROPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 93 LATIN AMERICA: MICROPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 94 MIDDLE EAST: MICROPLATES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 95 GCC COUNTRIES: MICROPLATES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 96 CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 97 CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 98 NORTH AMERICA: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 99 EUROPE: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 101 LATIN AMERICA: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 102 MIDDLE EAST: CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 103 GCC COUNTRIES: CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 104 IMMORTALIZED CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 105 NORTH AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 106 EUROPE: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 107 ASIA PACIFIC: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 108 LATIN AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 109 MIDDLE EAST: IMMORTALIZED CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 110 GCC COUNTRIES: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 111 PRIMARY CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 112 NORTH AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 113 EUROPE: PRIMARY CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 114 ASIA PACIFIC: PRIMARY CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 115 LATIN AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 116 MIDDLE EAST: PRIMARY CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 117 GCC COUNTRIES: PRIMARY CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 118 STEM CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 119 NORTH AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 120 EUROPE: STEM CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 121 ASIA PACIFIC: STEM CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 122 LATIN AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 123 MIDDLE EAST: STEM CELL LINES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 124 GCC COUNTRIES: STEM CELL LINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 125 PROBES & LABELS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 126 NORTH AMERICA: PROBES & LABELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 127 EUROPE: PROBES & LABELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: PROBES & LABELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 129 LATIN AMERICA: PROBES & LABELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 130 MIDDLE EAST: PROBES & LABELS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 131 GCC COUNTRIES: PROBES & LABELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 132 OTHER CONSUMABLES OFFERED, BY KEY COMPANY
  • TABLE 133 OTHER CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 134 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 135 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 137 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 138 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 139 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 140 INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 141 NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 142 EUROPE: INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 144 LATIN AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 145 MIDDLE EAST: INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 146 GCC COUNTRIES: INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 147 SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 148 NORTH AMERICA: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 149 EUROPE: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 151 LATIN AMERICA: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 152 MIDDLE EAST: SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 153 GCC COUNTRIES: SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 154 SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 155 NORTH AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 156 EUROPE: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 157 ASIA PACIFIC: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 158 LATIN AMERICA: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 159 MIDDLE EAST: SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 160 GCC COUNTRIES: SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 161 CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 162 CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 163 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 164 EUROPE: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 166 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 167 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 168 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 169 CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 170 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 171 EUROPE: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 173 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 174 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 175 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 176 CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 177 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 178 EUROPE: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 179 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 180 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 181 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 182 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 183 OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 184 NORTH AMERICA: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 185 EUROPE: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 186 ASIA PACIFIC: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 187 LATIN AMERICA: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 188 MIDDLE EAST: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 189 GCC COUNTRIES: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 190 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 191 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 192 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 193 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 194 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 195 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 196 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 197 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 198 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 199 CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 200 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 201 EUROPE: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 202 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 203 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 204 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 205 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 206 CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 207 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 208 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 209 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 210 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 211 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 212 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 213 CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 214 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 215 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 216 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 217 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 218 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 219 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 220 CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 221 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 222 EUROPE: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 223 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 224 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 225 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 227 CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 228 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 229 EUROPE: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 230 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 231 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 232 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 233 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 234 CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 235 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 236 EUROPE: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 237 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 238 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 239 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 240 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 241 CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 242 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION)
  • TABLE 243 CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 244 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 245 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 246 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 247 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 248 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 249 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 250 CELL-BASED ASSAYS MARKET FOR CROS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 251 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 252 EUROPE: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 253 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 254 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 255 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR CROS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 256 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 257 CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 258 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 259 EUROPE: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 260 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 261 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 262 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 263 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 264 CELL-BASED ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 265 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 266 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 267 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 268 NORTH AMERICA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 269 NORTH AMERICA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 270 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 271 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 272 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 273 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 274 US: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 275 US: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 276 US: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 277 US: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 278 US: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 279 US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 280 US: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 281 US: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 282 CANADA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 283 CANADA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 284 CANADA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 285 CANADA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 286 CANADA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 287 CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 288 CANADA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 289 CANADA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 290 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 291 EUROPE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 292 EUROPE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 293 EUROPE: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 294 EUROPE: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 295 EUROPE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 296 EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 297 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 298 EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 299 GERMANY: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 300 GERMANY: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 301 GERMANY: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 302 GERMANY: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 303 GERMANY: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 304 GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 305 GERMANY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 306 GERMANY: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 307 UK: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 308 UK: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 309 UK: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 310 UK: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 311 UK: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 312 UK: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 313 UK: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 314 UK: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 315 FRANCE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 316 FRANCE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 317 FRANCE: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 318 FRANCE: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 319 FRANCE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 320 FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 321 FRANCE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 322 FRANCE: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 323 ITALY: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 324 ITALY: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 325 ITALY: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 326 ITALY: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 327 ITALY: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 328 ITALY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 329 ITALY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 330 ITALY: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 331 SPAIN: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 332 SPAIN: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 333 SPAIN: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 334 SPAIN: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 335 SPAIN: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 336 SPAIN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 337 SPAIN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 338 SPAIN: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 339 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 340 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 341 REST OF EUROPE: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 342 REST OF EUROPE: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 343 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 344 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 345 REST OF EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 346 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 347 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 348 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 349 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 350 ASIA PACIFIC: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 351 ASIA PACIFIC: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 352 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 353 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 354 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 355 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 356 CHINA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 357 CHINA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 358 CHINA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 359 CHINA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 360 CHINA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 361 CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 362 CHINA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 363 CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 364 JAPAN: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 365 JAPAN: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 366 JAPAN: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 367 JAPAN: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 368 JAPAN: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 369 JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 370 JAPAN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 371 JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 372 INDIA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 373 INDIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 374 INDIA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 375 INDIA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 376 INDIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 377 INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 378 INDIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 379 INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 380 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 381 AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 382 AUSTRALIA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 383 AUSTRALIA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 384 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 385 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 386 AUSTRALIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 387 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 388 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 389 SOUTH KOREA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 390 SOUTH KOREA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 391 SOUTH KOREA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 392 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 393 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 394 SOUTH KOREA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 395 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 396 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 397 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 398 REST OF ASIA PACIFIC: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 399 REST OF ASIA PACIFIC: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 400 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 401 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 402 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 403 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 404 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 405 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 406 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 407 LATIN AMERICA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 408 LATIN AMERICA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 409 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 410 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 411 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 412 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 413 BRAZIL: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 414 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 415 BRAZIL: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 416 BRAZIL: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 417 BRAZIL: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 418 BRAZIL: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 419 BRAZIL: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 420 BRAZIL: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 421 MEXICO: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 422 MEXICO: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 423 MEXICO: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 424 MEXICO: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 425 MEXICO: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 426 MEXICO: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 427 MEXICO: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 428 MEXICO: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 429 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 430 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 431 REST OF LATIN AMERICA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 432 REST OF LATIN AMERICA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 433 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 434 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 435 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 436 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 437 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 438 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 439 MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 440 MIDDLE EAST: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 441 MIDDLE EAST: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 442 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 443 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 444 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 445 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 446 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 447 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 448 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 449 GCC COUNTRIES: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 450 GCC COUNTRIES: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 451 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 452 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 453 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 454 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 455 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 456 SAUDI ARABIA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 457 SAUDI ARABIA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 458 SAUDI ARABIA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 459 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 460 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 461 SAUDI ARABIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 462 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 463 UAE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 464 UAE: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 465 UAE: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 466 UAE: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 467 UAE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 468 UAE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 469 UAE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 470 UAE: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 471 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 472 REST OF GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 473 REST OF GCC COUNTRIES: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 474 REST OF GCC COUNTRIES: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 475 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 476 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 477 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 478 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 479 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 480 REST OF MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 481 REST OF MIDDLE EAST: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 482 REST OF MIDDLE EAST: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 483 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 484 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 485 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 486 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 487 AFRICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
  • TABLE 488 AFRICA: CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 489 AFRICA: ASSAY KITS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 490 AFRICA: CELL LINES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 491 AFRICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • TABLE 492 AFRICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 493 AFRICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 494 AFRICA: CELL-BASED ASSAYS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 495 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • TABLE 496 CELL-BASED ASSAYS MARKET: DEGREE OF COMPETITION
  • TABLE 497 CELL-BASED ASSAYS MARKET: OFFERING FOOTPRINT
  • TABLE 498 CELL-BASED ASSAYS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 499 CELL-BASED ASSAYS MARKET: APPLICATION FOOTPRINT
  • TABLE 500 CELL-BASED ASSAYS MARKET: REGION FOOTPRINT
  • TABLE 501 CELL-BASED ASSAYS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 502 CELL-BASED ASSAYS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 503 CELL-BASED ASSAYS MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021-AUGUST 2024
  • TABLE 504 CELL-BASED ASSAYS MARKET: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 505 CELL-BASED ASSAYS MARKET: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 506 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 507 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 508 DANAHER CORPORATION DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 509 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 510 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 511 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 512 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 513 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 514 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 515 MERCK KGAA: PRODUCTS/SERVICES OFFERED
  • TABLE 516 MERCK KGAA: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 517 MERCK KGAA (GERMANY): EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 518 BD: BUSINESS OVERVIEW
  • TABLE 519 BD: PRODUCTS/SERVICES OFFERED
  • TABLE 520 BD: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 521 BD: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 522 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 523 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 524 AGILENT TECHNOLOGIES, INC.: PRODUCTS LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 525 LONZA: COMPANY OVERVIEW
  • TABLE 526 LONZA: PRODUCTS/SERVICES OFFERED
  • TABLE 527 LONZA: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 528 LONZA: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 529 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 530 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
  • TABLE 531 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 532 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 533 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED
  • TABLE 534 CHARLES RIVER LABORATORIES: SERVICE LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 535 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021-AUGUST 2024
  • TABLE 536 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 537 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 538 REVVITY: COMPANY OVERVIEW
  • TABLE 539 REVVITY: PRODUCTS/SERVICES OFFERED
  • TABLE 540 REVVITY: PRODUCT LAUNCHES, JANUARY 2021-AUGUST 2024
  • TABLE 541 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 542 SARTORIUS AG: PRODUCTS/SERVICES OFFERED
  • TABLE 543 SARTORIUS AG: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 544 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 545 CORNING INCORPORATED: PRODUCTS/SERVICES OFFERED
  • TABLE 546 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 547 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 548 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW
  • TABLE 549 CELL SIGNALING TECHNOLOGY, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 550 ENZO BIOCHEM INC.: COMPANY OVERVIEW
  • TABLE 551 ENZO BIOCHEM INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 552 ENZO BIOCHEM INC.: EXPANSIONS, JANUARY 2021-AUGUST 2024
  • TABLE 553 CARNA BIOSCIENCES, INC.: BUSINESS OVERVIEW
  • TABLE 554 CARNA BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 555 INTERTEK GROUP PLC: COMPANY OVERVIEW
  • TABLE 556 INTERTEK GROUP: PRODUCTS /SERVICES OFFERED
  • TABLE 557 BICO: COMPANY OVERVIEW
  • TABLE 558 BICO: PRODUCTS/SERVICES OFFERED

List of Figures

  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 BREAKDOWN OF PRIMARIES: CELL-BASED ASSAYS MARKET
  • FIGURE 3 CELL-BASED ASSAYS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
  • FIGURE 5 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS (2023)
  • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 8 CELL-BASED ASSAYS MARKET: CAGR PROJECTIONS
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 CELL-BASED ASSAYS MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 CELL-BASED ASSAYS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF CELL-BASED ASSAYS MARKET
  • FIGURE 15 GROWING DEMAND FOR DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET
  • FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2023
  • FIGURE 17 CONSUMABLES SEGMENT ACCOUNTED FOR LARGER MARKET SHARE IN 2023
  • FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT HELD MAJOR MARKET SHARE IN 2023
  • FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 20 CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 21 AGE-STANDARDIZED RATE (WORLD) PER 100,000 CANCER INCIDENCES IN BOTH SEXES, 2022
  • FIGURE 22 CELL-BASED ASSAYS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 23 CELL-BASED ASSAYS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 24 PRICING ANALYSIS FOR CELL-BASED ASSAY PRODUCTS
  • FIGURE 25 CELL-BASED ASSAYS MARKET ECOSYSTEM
  • FIGURE 26 REVENUE SHIFTS IN CELL-BASED ASSAYS MARKET
  • FIGURE 27 NUMBER OF PATENTS GRANTED, 2014-2023
  • FIGURE 28 TOP TEN PATENT APPLICANTS, 2014-2024
  • FIGURE 29 CELL-BASED ASSAYS MARKET: PORTERS FIVE ANALYSIS
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL-BASED ASSAY PRODUCTS
  • FIGURE 31 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 32 CELL-BASED ASSAYS MARKET: INVESTMENTS & FUNDING SCENARIO
  • FIGURE 33 INSTRUMENTS MARKET (FLOW CYTOMETERS) FOR CELL-BASED ASSAYS, 2022-2029 (THOUSAND UNITS)
  • FIGURE 34 WORLDWIDE TOTAL PHARMACEUTICAL R&D SPEND, 2021-2028
  • FIGURE 35 NORTH AMERICA: CELL-BASED ASSAYS MARKET SNAPSHOT
  • FIGURE 36 ASIA PACIFIC: CELL-BASED ASSAYS MARKET SNAPSHOT
  • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN CELL-BASED ASSAYS MARKET (2021-2023)
  • FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL-BASED ASSAYS MARKET (2023)
  • FIGURE 39 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 40 CELL-BASED ASSAYS MARKET: COMPANY FOOTPRINT
  • FIGURE 41 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2023
  • FIGURE 42 EV/EBITDA OF KEY VENDORS
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 44 CELL-BASED ASSAYS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 46 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 47 MERCK KGAA: COMPANY SNAPSHOT (2023)
  • FIGURE 48 BD: COMPANY SNAPSHOT (2023)
  • FIGURE 49 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 50 LONZA: COMPANY SNAPSHOT (2023)
  • FIGURE 51 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
  • FIGURE 52 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2023)
  • FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 54 REVVITY: COMPANY SNAPSHOT (2023)
  • FIGURE 55 SARTORIUS AG: COMPANY SNAPSHOT (2023)
  • FIGURE 56 CORNING INCORPORATED: COMPANY SNAPSHOT (2023)
  • FIGURE 57 ENZO BIOCHEM INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 58 CARNA BIOSCIENCES, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 59 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2023)
  • FIGURE 60 BICO: COMPANY SNAPSHOT (2023)